| Mar 4, 2026 |
Mar 6, 2026 |
Pauling David
|
Chief Admin. Ofcr. & GC |
Sell |
47.5
|
-277
|
-2.76%
|
✗
|
$5.9K |
| Mar 4, 2026 |
Mar 6, 2026 |
Chung Jane
|
CEO |
Sell |
47.5
|
-282
|
-1.31%
|
✗
|
$6K |
| Mar 1, 2026 |
Mar 3, 2026 |
Pauling David
|
Chief Admin. Ofcr. & GC |
Sell |
46.3
|
-1,521
|
-8.08%
|
✗
|
$31.2K |
| Mar 1, 2026 |
Mar 3, 2026 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Sell |
46.3
|
-1,633
|
-8.60%
|
✗
|
$33.5K |
| Mar 2, 2026 |
Mar 3, 2026 |
Chow Gregory K.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 1, 2026 |
Mar 3, 2026 |
Chung Jane
|
CEO |
Sell |
42.5
|
-4,050
|
-9.97%
|
✗
|
$83.1K |
| Dec 23, 2025 |
Dec 29, 2025 |
Wigginton Jon Marc
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Petree Daniel H
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
PANEK JAMES P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
MATSUI CONNIE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Lobacki Joseph M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Jagpal Sukhi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Hunter Heidi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Dybbs Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Pauling David
|
Chief Admin. Ofcr. & GC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 23, 2025 |
Dec 29, 2025 |
Chow Gregory K.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 12, 2025 |
Dec 16, 2025 |
Chung Jane
|
CEO |
Sell |
47.5
|
-894
|
-6.05%
|
✗
|
$7.2K |
| Oct 15, 2025 |
Oct 16, 2025 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Buy |
91.3
|
+17,000
|
31.00%
|
✗
|
$13.6K |
| Oct 15, 2025 |
Oct 16, 2025 |
Chow Gregory K.
|
CFO |
Buy |
91.3
|
+19,750
|
100.00%
|
✗
|
$16K |
| Oct 15, 2025 |
Oct 16, 2025 |
Chung Jane
|
CEO |
Buy |
91.3
|
+12,500
|
11.33%
|
✗
|
$10K |
| Oct 15, 2025 |
Oct 16, 2025 |
MATSUI CONNIE
|
Director |
Buy |
91.3
|
+50,000
|
100.00%
|
✗
|
$40K |
| Oct 15, 2025 |
Oct 16, 2025 |
Pauling David
|
Chief Admin. Ofcr. & GC |
Buy |
90.0
|
+12,504
|
21.11%
|
✗
|
$10K |
| Sep 18, 2025 |
Sep 22, 2025 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Sell |
46.3
|
-13,417
|
-19.66%
|
✗
|
$12.1K |
|
Sep 12, 2025 |
Pauling David
|
Chief Admin. Ofcr. & GC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 8, 2025 |
Aug 26, 2025 |
Leyman Barbara
|
Chief Business Officer |
Sell |
47.5
|
-8,944
|
-35.78%
|
✗
|
$7K |
| Aug 9, 2025 |
Aug 26, 2025 |
Chung Jane
|
CEO |
Sell |
47.5
|
-6,708
|
-5.73%
|
✗
|
$5.4K |
| Jun 6, 2025 |
Jun 10, 2025 |
Wigginton Jon Marc
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
Petree Daniel H
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
PANEK JAMES P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
MATSUI CONNIE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
Lobacki Joseph M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
Jagpal Sukhi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
Hunter Heidi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2025 |
Jun 10, 2025 |
Dybbs Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 2, 2025 |
Jun 2, 2025 |
Chow Gregory K.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 2, 2025 |
Chow Gregory K.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
ALBINI EDWARD C
|
CFO |
Sell |
46.3
|
-15,995
|
-9.05%
|
✗
|
$14.1K |
| May 1, 2025 |
May 5, 2025 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Sell |
46.3
|
-13,538
|
-9.42%
|
✗
|
$14.5K |
| May 1, 2025 |
May 5, 2025 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Sell |
47.5
|
-894
|
-1.64%
|
✗
|
$956.6 |
| May 1, 2025 |
May 5, 2025 |
Borgman Anne Elizabeth
|
CHIEF MEDICAL OFFICER |
Sell |
46.3
|
-24,709
|
-20.23%
|
✗
|
$26.4K |
| Apr 11, 2025 |
Apr 15, 2025 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Sell |
47.5
|
-7,603
|
-12.74%
|
✗
|
$4.6K |
| Apr 4, 2025 |
Apr 8, 2025 |
Chung Jane
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2025 |
Apr 8, 2025 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2025 |
Apr 8, 2025 |
Leyman Barbara
|
Chief Business Dev. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2025 |
Apr 8, 2025 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 4, 2025 |
Apr 8, 2025 |
Pauling David
|
Chief Admin. Ofcr. & GC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 8, 2025 |
Pauling David
|
Chief Admin. Ofcr. & GC |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2025 |
Mar 7, 2025 |
NEWELL WILLIAM J
|
CEO |
Sell |
47.5
|
-6,708
|
-1.61%
|
✗
|
$9.1K |
| Mar 5, 2025 |
Mar 7, 2025 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Sell |
47.5
|
-3,594
|
-3.28%
|
✗
|
$4.9K |
| Mar 5, 2025 |
Mar 7, 2025 |
ALBINI EDWARD C
|
CFO |
Sell |
47.5
|
-3,594
|
-2.65%
|
✗
|
$4.9K |
| Mar 4, 2025 |
Mar 6, 2025 |
ALBINI EDWARD C
|
CFO |
Sell |
47.5
|
-3,748
|
-2.87%
|
✗
|
$5.3K |
| Mar 4, 2025 |
Mar 6, 2025 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Sell |
47.5
|
-3,748
|
-3.59%
|
✗
|
$5.3K |
| Mar 4, 2025 |
Mar 6, 2025 |
NEWELL WILLIAM J
|
CEO |
Sell |
46.3
|
-11,136
|
-2.73%
|
✗
|
$15.8K |
| Mar 4, 2025 |
Mar 6, 2025 |
Chung Jane
|
COO |
Sell |
47.5
|
-2,334
|
-2.32%
|
✗
|
$3.3K |
| Mar 1, 2025 |
Mar 4, 2025 |
ALBINI EDWARD C
|
CFO |
Sell |
46.3
|
-10,320
|
-7.83%
|
✗
|
$16.4K |
| Mar 1, 2025 |
Mar 4, 2025 |
Chung Jane
|
COO |
Sell |
46.3
|
-9,450
|
-9.25%
|
✗
|
$15K |
| Mar 1, 2025 |
Mar 4, 2025 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Sell |
46.3
|
-8,327
|
-8.04%
|
✗
|
$13.2K |
| Mar 1, 2025 |
Mar 4, 2025 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Sell |
47.5
|
-4,621
|
-13.06%
|
✗
|
$7.3K |
| Mar 1, 2025 |
Mar 4, 2025 |
NEWELL WILLIAM J
|
CEO |
Sell |
46.3
|
-25,203
|
-6.27%
|
✗
|
$40.1K |
| Mar 1, 2025 |
Mar 4, 2025 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Sell |
47.5
|
-4,672
|
-10.84%
|
✗
|
$7.4K |
| Feb 28, 2025 |
Mar 4, 2025 |
Borgman Anne Elizabeth
|
CHIEF MEDICAL OFFICER |
Sell |
46.3
|
-20,026
|
-16.75%
|
✗
|
$31.8K |
| Dec 1, 2024 |
Dec 3, 2024 |
Chung Jane
|
COO |
Sell |
46.3
|
-8,920
|
-11.25%
|
✗
|
$24K |
| Sep 18, 2024 |
Sep 20, 2024 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Sell |
42.5
|
-13,380
|
-35.68%
|
✗
|
$52.9K |
| Aug 9, 2024 |
Aug 13, 2024 |
Chung Jane
|
COO |
Sell |
46.3
|
-6,689
|
-10.97%
|
✗
|
$20.9K |
| Aug 8, 2024 |
Aug 12, 2024 |
Jagpal Sukhi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 12, 2024 |
Jagpal Sukhi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 8, 2024 |
Jul 10, 2024 |
Leyman Barbara
|
Chief Business Dev. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jul 10, 2024 |
Leyman Barbara
|
Chief Business Dev. Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
Wigginton Jon Marc
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
Petree Daniel H
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
PANEK JAMES P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
MATSUI CONNIE
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
Lobacki Joseph M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
Hunter Heidi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
Freund John Gordon
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2024 |
Jun 10, 2024 |
Dybbs Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2024 |
May 3, 2024 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Sell |
47.5
|
-892
|
-2.73%
|
✗
|
$3.3K |
| Apr 11, 2024 |
Apr 12, 2024 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Sell |
46.3
|
-7,582
|
-20.11%
|
✗
|
$34.1K |
| Mar 5, 2024 |
Mar 22, 2024 |
NEWELL WILLIAM J
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2024 |
Mar 22, 2024 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2024 |
Mar 22, 2024 |
ALBINI EDWARD C
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2024 |
Mar 7, 2024 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Sell |
46.3
|
-3,108
|
-3.60%
|
✗
|
$14.1K |
| Mar 5, 2024 |
Mar 7, 2024 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2024 |
Mar 7, 2024 |
NEWELL WILLIAM J
|
CEO |
Sell |
46.3
|
-6,690
|
-1.95%
|
✗
|
$30.4K |
| Mar 5, 2024 |
Mar 7, 2024 |
Gerber Hans-Peter
|
CHIEF SCIENTIFIC OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2024 |
Mar 7, 2024 |
Chung Jane
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2024 |
Mar 7, 2024 |
Borgman Anne Elizabeth
|
CHIEF MEDICAL OFFICER |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 5, 2024 |
Mar 7, 2024 |
ALBINI EDWARD C
|
CFO |
Sell |
46.3
|
-3,100
|
-2.82%
|
✗
|
$14.1K |
| Mar 4, 2024 |
Mar 6, 2024 |
NEWELL WILLIAM J
|
CEO |
Sell |
42.5
|
-11,105
|
-3.31%
|
✗
|
$53.2K |
| Mar 4, 2024 |
Mar 6, 2024 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Sell |
46.3
|
-3,739
|
-4.59%
|
✗
|
$17.9K |
| Mar 4, 2024 |
Mar 6, 2024 |
Chung Jane
|
COO |
Sell |
46.3
|
-2,209
|
-4.97%
|
✗
|
$10.6K |
| Mar 4, 2024 |
Mar 6, 2024 |
ALBINI EDWARD C
|
CFO |
Sell |
46.3
|
-3,472
|
-3.32%
|
✗
|
$16.6K |
| Mar 1, 2024 |
Mar 5, 2024 |
Srinivasan Venkatesh
|
CHIEF TECH OP OFFICER |
Sell |
46.3
|
-2,049
|
-11.07%
|
✗
|
$10.1K |
| Mar 1, 2024 |
Mar 5, 2024 |
NEWELL WILLIAM J
|
CEO |
Sell |
46.3
|
-8,559
|
-2.73%
|
✗
|
$42.4K |
| Mar 1, 2024 |
Mar 5, 2024 |
FITZPATRICK LINDA A
|
CHIEF PEOPLE & COMM. OFFICER |
Sell |
46.3
|
-2,511
|
-3.36%
|
✗
|
$12.4K |
| Mar 1, 2024 |
Mar 5, 2024 |
Chung Jane
|
COO |
Sell |
46.3
|
-2,038
|
-5.28%
|
✗
|
$10.1K |
| Mar 1, 2024 |
Mar 5, 2024 |
ALBINI EDWARD C
|
CFO |
Sell |
46.3
|
-3,227
|
-3.27%
|
✗
|
$16K |
| Feb 29, 2024 |
Mar 4, 2024 |
Borgman Anne Elizabeth
|
CHIEF MEDICAL OFFICER |
Sell |
42.5
|
-13,126
|
-35.00%
|
✗
|
$64.4K |
| Jan 29, 2024 |
Jan 31, 2024 |
NEWELL WILLIAM J
|
CEO |
Sell |
46.3
|
-5,634
|
-1.91%
|
✗
|
$28.1K |